HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 65910Generated: October 23, 2026
Emitefur
BOF-A2 · BOF-A-2 · EMITEFUR · EMITEFUR USP/EP/BP · 3-[[3-(Ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrim-idinyl]carbonyl]benzoic acid 6-(benzoyloxy)- 3-cyano-2-pyridinyl ester · 3-[[3-(Ethoxymethyl)-5-fluoro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-1-yl]carbonyl]benzoic acid 6-(benzoyloxy)-3-cyano-2-pyridyl ester · Benzoic acid, 3-[[3-(ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl]carbonyl]-, 6-(benzoyloxy)-3-cyano-2-pyridinyl ester · 3-[[[3-(Ethoxymethyl)-5-fluoro-1,2,3,6-tetrahydro-2,6-dioxopyrimidin]-1-yl]carbonyl]benzoic acid 6-(benzoyloxy)-3-cyano-2-pyridinyl ester
https://huagongshe.com/en/chemical/65910

Identifiers & Physical Properties
| CAS No. | 110690-43-2 |
|---|
| Molecular formula | C28H19FN4O8 |
|---|
| Average molar mass | 558.5 g/mol |
|---|
| Monoisotopic mass | 558.11869179 g/mol |
|---|
| SMILES | CCOCn1cc(F)c(=O)n(C(=O)c2cccc(C(=O)Oc3nc(OC(=O)c4ccccc4)ccc3C#N)c2)c1=O |
|---|
| InChIKey | WTSKMKRYHATLLL-UHFFFAOYSA-N |
|---|
| PubChem CID | 65910 |
|---|
| ChEMBL | CHEMBL2104592 |
|---|
| DTXSID | DTXSID80149360 |
|---|
Chemical & Physical Properties
| XLogP | 3.6 |
|---|
| Topological polar surface area | 156 |
|---|
| Hydrogen bond donors | 0 |
|---|
| Hydrogen bond acceptors | 11 |
|---|
| Rotatable bonds | 10 |
|---|
| Heavy atoms | 41 |
|---|
| Formal charge | 0 |
|---|
| Complexity | 1,110 |
|---|
| Melting point | 162-164° |
|---|
| Boiling point | 755.1±70.0 °C(Predicted) |
|---|
| Density | 1.52±0.1 g/cm3(Predicted) |
|---|
| Storage conditions | 2-8°C |
|---|
| pKa (acidity coefficient) | -5.94±0.40(Predicted) |
|---|
| CAS DataBase Reference | 110690-43-2 |
|---|
| NCI Dictionary of Cancer Terms | emitefur |
|---|
| FDA UNII | 9I50NF4AQ2 |
|---|
| Toxicity | LD50 in mice, male rats, female rats (mg/kg): >5000, 1850, 1934 orally (Kiroshita) |
|---|
Safety & Regulations
| Toxicity | LD50 in mice, male rats, female rats (mg/kg): >5000, 1850, 1934 orally (Kiroshita) |
|---|
Applications & Uses
Uses
EMITEFUR is used for antineoplastic, it is used in the treatment of stomach, colorectal, breast, nonsmall cell lung, and pancreatic cancers (inhibits DNA synthesis and RNA function).